Tan, Q., Chi, Y., Chi, Y., Su, M., Zhou, J., Zhou, D., . . . Li, H. (2023). Potential predictive value of circulating tumor DNA (ctDNA) mutations for the efficacy of immune checkpoint inhibitors in advanced triple-negative breast cancer. Frontiers Media S.A.
Chicago Style (17th ed.) CitationTan, Qiaorui, et al. Potential Predictive Value of Circulating Tumor DNA (ctDNA) Mutations for the Efficacy of Immune Checkpoint Inhibitors in Advanced Triple-negative Breast Cancer. Frontiers Media S.A, 2023.
MLA (9th ed.) CitationTan, Qiaorui, et al. Potential Predictive Value of Circulating Tumor DNA (ctDNA) Mutations for the Efficacy of Immune Checkpoint Inhibitors in Advanced Triple-negative Breast Cancer. Frontiers Media S.A, 2023.
Warning: These citations may not always be 100% accurate.